Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

416 ARTÍCULOS , VIENDO DEL 196 AL 210

Focus on the Correlations between Alzheimer's Disease and Type 2 Diabetes

Fiore V, De Rosa A, Falasca P, Marci M, Guastamacchia E, Licchelli B, Giagulli VA, De Pergola G, Poggi A, Triggiani V.

Endocr Metab Immune Disord Drug Targets. 2019;19(5):571-579. doi: 10.2174/1871530319666190311141855.

Efficacy of rivastigmine transdermal therapy on low food intake in patients with Alzheimer's disease: The Attitude Towards Food Consumption in Alzheimer's Disease Patients Revive with Rivastigmine Effects study

Tsuno N, Mori T, Ishikawa I, Bando N, Park H, Matsumoto Y, Mori I, Tanaka M, Hirano T, Nakamura Y.

Geriatr Gerontol Int. 2019 Jul;19(7):571-576. doi: 10.1111/ggi.13644. Epub 2019 Mar 12.

Metabolic Syndrome, Mild Cognitive Impairment, and Dementia: A Meta-Analysis of Longitudinal Studies

Atti AR, Valente S, Iodice A, Caramella I, Ferrari B, Albert U, Mandelli L, De Ronchi D.

Am J Geriatr Psychiatry. 2019 Jun;27(6):625-637. doi: 10.1016/j.jagp.2019.01.214. Epub 2019 Feb 15.

An urgent need to assess safe levels of inorganic copper in nutritional supplements/parenteral nutrition for subset of Alzheimer's disease patients

Kumar A, Sharma P, Prasad R, Pal A.

Neurotoxicology. 2019 Jul;73:168-174. doi: 10.1016/j.neuro.2019.04.001. Epub 2019 Apr 4.

APOE ɛ4 and REM Sleep Behavior Disorder as Risk Factors for Sundown Syndrome in Alzheimer's Disease

Pyun JM, Kang MJ, Yun Y, Park YH, Kim S.

J Alzheimers Dis. 2019;69(2):521-528. doi: 10.3233/JAD-190032.

Efficacy and Limitations of rCBF-SPECT in the Diagnosis of Alzheimer's Disease With Amyloid-PET

Takahashi M, Tada T, Nakamura T, Koyama K, Momose T.

Am J Alzheimers Dis Other Demen. 2019 Aug;34(5):314-321. doi: 10.1177/1533317519841192. Epub 2019 Apr 9.

Randomized Trial of Verubecestat for Prodromal Alzheimer's Disease

Egan MF, Kost J, Voss T, Mukai Y, Aisen PS, Cummings JL, Tariot PN, Vellas B, van Dyck CH, Boada M, Zhang Y, Li W, Furtek C, Mahoney E, Harper Mozley L, Mo Y, Sur C, Michelson D.

N Engl J Med. 2019 Apr 11;380(15):1408-1420. doi: 10.1056/NEJMoa1812840.

The Limitations of Using Cognitive Cutoff Scores for Enrollment in Alzheimer Trials

Patrick RE, Hobbs K, Mathias L, Harper DG, Forester BP.

Am J Geriatr Psychiatry. 2019 Oct;27(10):1153-1158. doi: 10.1016/j.jagp.2019.02.014. Epub 2019 Mar 1.

Recruitment of Older Veterans with Diabetes Risk for Alzheimer's Disease for a Randomized Clinical Trial of Computerized Cognitive Training

Karran M, Guerrero-Berroa E, Schmeidler J, Lee PG, Alexander N, Nabozny M, West RK, Beeri MS, Sano M, Silverman JM.

J Alzheimers Dis. 2019;69(2):401-411. doi: 10.3233/JAD-180952.

Atypical clinical features associated with mixed pathology in a case of non-fluent variant primary progressive aphasia

De Leon J, Mandelli ML, Nolan A, Miller ZA, Mead C, Watson C, Welch AE, Henry ML, Bourakova V, La Joie R, Bajorek LP, Grinberg L, Rabinovici G, Miller BL, Gorno-Tempini ML.

Neurocase. 2019 Feb-Apr;25(1-2):39-47. doi: 10.1080/13554794.2019.1609522. Epub 2019 Apr 29.

Clinical aspects of Alzheimer's disease

Zvěřová M.

Clin Biochem. 2019 Oct;72:3-6. doi: 10.1016/j.clinbiochem.2019.04.015. Epub 2019 Apr 26.

Rapid Reversal of Cognitive Decline, Olfactory Dysfunction, and Quality of Life Using Multi-Modality Photobiomodulation Therapy: Case Report

Salehpour F, Hamblin MR, DiDuro JO.

Photobiomodul Photomed Laser Surg. 2019 Mar;37(3):159-167. doi: 10.1089/photob.2018.4569.

Mood, lifestyle and cardiovascular risk factors among older caregivers of patients with Alzheimer's disease dementia: a case-control study

Madaleno TR, Moriguti JC, Ferriolli E, De Carlo MMRP, Lima NKC.

Aging Clin Exp Res. 2019 Nov;31(11):1609-1614. doi: 10.1007/s40520-019-01212-8. Epub 2019 May 9.

Association of Brain Magnetic Resonance Imaging Signs With Cognitive Outcomes in Persons With Nonimpaired Cognition and Mild Cognitive Impairment

Wu A, Sharrett AR, Gottesman RF, Power MC, Mosley TH Jr, Jack CR Jr, Knopman DS, Windham BG, Gross AL, Coresh J.

JAMA Netw Open. 2019 May 3;2(5):e193359. doi: 10.1001/jamanetworkopen.2019.3359.

Blood Pressure Lowering With Nilvadipine in Patients With Mild-to-Moderate Alzheimer Disease Does Not Increase the Prevalence of Orthostatic Hypotension

de Heus RAA, Donders R, Santoso AMM, Olde Rikkert MGM, Lawlor BA, Claassen JAHR; Nilvad Study Group.

J Am Heart Assoc. 2019 May 21;8(10):e011938. doi: 10.1161/JAHA.119.011938.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias